Bristol Myers (NYSE: BMY) CEO gets large equity grants and vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bristol Myers Squibb Chief Executive Officer Christopher S. Boerner reported multiple equity compensation transactions involving common stock and share units. On 2026-03-10, he exercised or settled 71,537 market share and performance share units into common stock and had 21,229 shares withheld at $60.13 per share to cover tax obligations and exercise costs.
He also received new long-term incentives, including 104,490 market share units and 156,735 performance share units that vest or convert based on multi-year performance conditions and Board certification. After these transactions, Boerner held 21,451 shares of common stock directly and 125,439 shares indirectly through a trust, reflecting compensation-related awards and routine tax withholding rather than open-market trading.
Positive
- None.
Negative
- None.
Insider Trade Summary
71,537 shares exercised/converted
Mixed
19 txns
Insider
BOERNER CHRISTOPHER S.
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Market Share Units | 6,618 | $0.00 | -- |
| Exercise | Market Share Units | 6,733 | $0.00 | -- |
| Exercise | Performance Shares | 40,398 | $0.00 | -- |
| Exercise | Performance Shares | 17,788 | $0.00 | -- |
| Grant/Award | Market Share Units | 104,490 | $0.00 | -- |
| Grant/Award | Performance Shares | 156,735 | $0.00 | -- |
| Exercise | Common Stock, $0.10 par value | 6,618 | $0.00 | -- |
| Other | Common Stock, $0.10 par value | 743 | $0.00 | -- |
| Tax Withholding | Common Stock, $0.10 par value | 3,006 | $60.13 | $181K |
| Exercise | Common Stock, $0.10 par value | 6,733 | $0.00 | -- |
| Other | Common Stock, $0.10 par value | 727 | $0.00 | -- |
| Tax Withholding | Common Stock, $0.10 par value | 3,073 | $60.13 | $185K |
| Exercise | Common Stock, $0.10 par value | 40,398 | $0.00 | -- |
| Other | Common Stock, $0.10 par value | 19,835 | $0.00 | -- |
| Tax Withholding | Common Stock, $0.10 par value | 10,518 | $60.13 | $632K |
| Exercise | Common Stock, $0.10 par value | 17,788 | $0.00 | -- |
| Other | Common Stock, $0.10 par value | 8,734 | $0.00 | -- |
| Tax Withholding | Common Stock, $0.10 par value | 4,632 | $60.13 | $279K |
| holding | Common Stock, $0.10 par value | -- | -- | -- |
Holdings After Transaction:
Market Share Units — 0 shares (Direct);
Performance Shares — 0 shares (Direct);
Common Stock, $0.10 par value — 7,800 shares (Direct);
Common Stock, $0.10 par value — 125,439 shares (Indirect, Trust (SLAT))
Footnotes (1)
- Represents vesting of one-quarter of market share units granted on March 10, 2022. Represents a downward adjustment to the number of shares acquired upon the vesting of market share units due to the performance factor. Shares withheld for payment of taxes upon vesting of awards. Represents vesting of one-quarter of market share units granted on March 10, 2023. Amount represents distribution of performance shares earned under the 2023-2025 Long-Term Performance Award. Adjustment to award based on the performance factor applied in accordance with the terms of the award and certification of performance results by the Board. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 80% and the maximum payout factor is 225%. Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2026. Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is the greater of Total Return and relative total shareholder return (rTSR) Floor. Total Return is a ratio of the 10-day average closing stock price on the measurement date, plus the value of accumulated dividends, divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor for Total Return performance that must be achieved to earn a payout is 80% and the maximum is 225%. The rTSR Floor feature provides a minimum level of payout if BMS stock price declines from the grant date but outperforms our peers based on their TSR percentile rank. A TSR percentile rank (i) below the 50th percentile yields a 0% payout, (ii) between the 50th and 74.99th percentiles yields a 50% payout, and (iii) at or above the 75th percentile yields a 100% payout. These market share units cliff vest on the third anniversary of the grant date, subject to certification of performance results by the Board. Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2029, subject to certification of performance results by the Board.
FAQ
What did BMY CEO Christopher Boerner report in this Form 4 filing?
Christopher Boerner reported equity compensation activity, not open-market trading. He exercised or settled 71,537 market share and performance share units into Bristol Myers Squibb common stock and had 21,229 shares withheld to satisfy tax and exercise obligations tied to these awards.
How many new equity awards did the BMY CEO receive in this Form 4?
The Form 4 shows Boerner received 104,490 market share units and 156,735 performance share units. These awards are part of long-term incentive programs, vest over several years, and depend on performance factors and Board certification before converting into Bristol Myers Squibb common shares.